Invest now
EVOQ Remedies share price
Extreme risk
You have to be logged in to add this to Watchlist.- ₹1.47(-4.55%)September 11, 2026 13:40:04 PM IST
- NSE
- BSE
- Vol : 72.00 K (NSE + BSE)Last 20 day avg : 40.00 K
EVOQ Remedies is trading -4.55% lower at Rs 1.47 as compared to its last closing price. EVOQ Remedies has been trading in the price range of 1.55 & 1.47. EVOQ Remedies has given -53.92% in this year & -5.77% in the last 5 days. The company posted a net profit of -0.29 Crores in its last quarter.Listed peers of EVOQ Remedies include Sun Pharmaceutical Industries (-1.18%), Divi's Laboratories (-0.84%), Torrent Pharmaceuticals (0.95%).The Mutual Fund holding in EVOQ Remedies was at -% in . The MF holding has - from the last quarter. The FII holding in EVOQ Remedies was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 15 Sep 2026, 08:29 AM IST
- BetaHigh volatility2.28Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.00The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
EVOQ Remedies Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,842.00 | -1.18 | 4,41,947.09 | 38.87 | 5.62 | 0.82 | 0.47 |
| Divi's Laboratories | 9,326.00 | -0.84 | 2,47,576.00 | 74.03 | 11.59 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,975.00 | 0.95 | 1,89,226.24 | 76.43 | 20.2 | 0.76 | 141.16 |
| Cipla | 1,365.00 | -1.09 | 1,10,191.95 | 28.01 | 3.38 | 0.90 | 1.11 |
| Zydus Lifesciences | 1,119.50 | 0.13 | 1,11,670.55 | 21.29 | 4.26 | 0.09 | 14.22 |
EVOQ Remedies Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-30 | Half Yearly Results |
| 2026-05-27 | Half Yearly Results |
| 2026-05-14 | Audited Results |
| 2025-10-10 | Quarterly Results |
| 2025-10-09 | Half Yearly Results |
About the company EVOQ Remedies
- IndustryBiotechnology & Drugs
- ISININE0JVD01011
- BSE Code543500
- NSE Code
EVOQ Remedies Limited is an India-based pharmaceutical company. The Company is engaged in the pharmaceutical business involving marketing, trading, and distribution of a range of pharmaceutical formulation products, such as antibiotic drugs, anti-malarial drugs, anti-allergic and cold drugs, analgesic/antipyretic and anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, antioxidants, and injections. It offers a range of pharmaceutical formulation products, of which around 120 products are marketed by the Company under its own brand name. The Company also deals in the trading of active pharmaceutical ingredients (APIs). Its products include Abacavir Sulfate, Acetazolamide, Acyclovir, Adefovir Dipivoxil Allylestrenole, Alpha Beta Arteether, Alpha Lipoic Acid, Alprazolam, Amoxycillin Trihydrate, Ampicillin Trihydrate, Artemether, Finasteride, Imipramine, Lidocaine, and more.
EVOQ Remedies Share Price FAQs
EVOQ Remedies is trading at 1.47 as on Fri Sep 11 2026 08:10:04. This is -4.55% lower as compared to its previous closing price of 1.54.
The market capitalization of EVOQ Remedies is 3.66 Cr as on Fri Sep 11 2026 08:10:04.
The 52 wk high for EVOQ Remedies is 6.11 whereas the 52 wk low is 1.47
EVOQ Remedies can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 29.71
- Dividend Yield: 0.00%
- D/E ratio: 0.00
EVOQ Remedies reported a net profit of -0.24 Cr in 2026.
Quick Links
EQUITY QUICK LINKS
EVOQ Remedies QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.